An interventional study of DASH-Style Diet and Western-Style Diet in Kidney Stone, sponsored by University of Alabama at Birmingham. Recruiting at 1 site in United States. Open to participants aged 19 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-01-13.
Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Kidney Calculi by University of Alabama at Birmingham — 6 open to participants now, 12 under way, none of them phase 3. Kidney Calculi · University of Alabama at Birmingham.
Among the 17 studies in Kidney Calculi by University of Alabama at Birmingham, this one is the 7th largest by planned enrollment, is one of 3 that started in 2025, is one of 17 with no phase, reaches primary completion later than 5 of the 11 other live ones, and was the 14th registered.
510 studies on the registry are indexed under Kidney Calculi; 147 are open to participants now.
Browse Kidney Calculi studies →6 of the 17 studies in Kidney Calculi by University of Alabama at Birmingham are open now, in 1 country. Recruiting first, the newest first:
University of Alabama at Birmingham · Sites in United States
Ages 18–80 · Healthy volunteers
University of Alabama at Birmingham · Sites in United States
Ages 18–80
University of Alabama at Birmingham · Sites in United States
Ages 18–80 · Healthy volunteers
University of Alabama at Birmingham · Sites in United States
Ages 18–60 · Healthy volunteers
University of Alabama at Birmingham · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 88 Kidney Calculi studies recruiting now, 48 (55%) set no upper age limit and 23 (26%) stop at 75 or younger; 6 take children under 18; 11 take healthy volunteers.
This study: 19 Years to 89 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 3 started in 2025.
This study's planned enrollment of 48 is below the median of 86 across 392 interventional studies indexed under Kidney Calculi.
Median enrollment 40 across the 17 interventional studies. Of the 4 that completed or were terminated, 4 (100%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Alabama at Birmingham is the lead sponsor of 1,422 studies on the registry; 277 are open to participants now.
Of its 164 completed or terminated interventional studies of FDA-regulated products, 130 (79%) have results posted.
4 of the studies in Kidney Calculi by University of Alabama at Birmingham that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04333745University of Alabama at BirminghamInfluence of Obesity on Oxalate Metabolism and Handling in Calcium Oxalate Stone Formers | 2026-12-01 |
| NCT04603898University of Alabama at BirminghamOxalate Formation From Ascorbic Acid | 2026-12-01 |
| NCT05417568University of Alabama at BirminghamOxalate-Driven Host Responses in Kidney Stone Disease | 2027-05-30 |
| NCT06210009University of Alabama at BirminghamEffect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease | 2027-08-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 17 studies in Kidney Calculi by University of Alabama at Birmingham, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The true capacity for a healthy diet to improve urinary stone risk factors is not well-defined. The objective of this study is to measure the effect of adopting a healthy dietary pattern on kidney stone disease (KSD) risk. The working hypothesis is that a Dietary Approaches to Stop Hypertension (DASH)-style diet will improve 24-hour urine stone risk parameters. The approach to testing this hypothesis will be to randomize participants with KSD to a standardized DASH-style vs. Western-style diet for one week. The Bionutrition Unit of the Center for Clinical and Translational Science will provide all meals to participants. The rationale for this study is that by measuring the effect of a DASH-style diet on urinary stone risk parameters, a benchmark for future real-world, implementation studies will be established. Based on available evidence, this will be the first controlled diet study to assess the DASH dietary pattern for improving urinary stone risk parameters.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
GFR and eGFR (kidney filtering)
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
For seven days, participants will consume a diet characterized by higher intake of fruits, vegetables, and low-fat dairy, in addition to whole grains, poultry, fish, and nuts, but smaller amounts of red meat, sweets, and sugar-containing beverages.
Other: DASH-Style Diet
For seven days, participants will consume a diet characterized by characterized by higher intake of red meat, sweets, and items containing added sugar, processed starches, and seed oils, in addition to lower intake of fruits, vegetables, and low-fat dairy.
Other: Western-Style Diet
Participants will be randomized to a DASH-style diet
Participants will be randomized to a Western-style diet
Difference between the two arms in supersaturation of calcium oxalate
Supersaturation of calcium oxalate is an index reflecting the propensity for the formation and growth of the most common stone type (calcium oxalate), which is calculated using excretion rates including urinary volume, calcium, citrate, and oxalate.
Time frame: Days 6-7 of the assigned intervention
Difference between the two arms in supersaturation of calcium oxalate between the baseline and intervention periods
This secondary outcome will be calculated using a difference in differences approach.
Time frame: Days 6-7 of the assigned intervention
Difference between the two arms in supersaturation of uric acid
Supersaturation of uric acid is an index reflecting the propensity for the formation and growth of uric acid stones.
Time frame: Days 6-7 of the assigned intervention
Difference between the two arms in supersaturation of calcium phosphate
Supersaturation of calcium phosphate is an index reflecting the propensity for the formation and growth of calcium phosphate stones.
Time frame: Days 6-7 of the assigned intervention
Difference between the two arms in urine volume
Low urine volume is a stone risk factor.
Time frame: Days 6-7 of the assigned intervention
Difference between the two arms in urine calcium
High urine calcium is a stone risk factor.
Time frame: Days 6-7 of the assigned intervention
Difference between the two arms in urine oxalate
High urine oxalate is a stone risk factor.
Time frame: Days 6-7 of the assigned intervention
Difference between the two arms in urine citrate
Low urine citrate is a stone risk factor.
Time frame: Days 6-7 of the assigned intervention
Difference between the two arms in urine uric acid
High urine uric acid is a stone risk factor.
Time frame: Days 6-7 of the assigned intervention
Difference between the two arms in urine pH
Urine pH can influence stone formation and growth.
Time frame: Days 6-7 of the assigned intervention
Started Jan 2025 (actual). Primary completion is estimated for Aug 2027, 31 months after the start.
Of 183 non-industry interventional studies with no phase under Kidney Calculi, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's planned 31 months is close to that.
Counting every sponsor, half of 199 studies reached it within 26 months; a quarter within 12 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Alabama at Birmingham →